GSK PLC (LSE:GSK)
£ 18.1 0.105 (0.58%) Market Cap: 73.81 Bil Enterprise Value: 87.49 Bil PE Ratio: 17.87 PB Ratio: 5.33 GF Score: 77/100

GlaxoSmithKline PLC at Morgan Stanley ESG Insights Conference (Virtual) Transcript

Dec 09, 2020 / 03:25PM GMT
Release Date Price: £14.09 (-0.44%)
Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst

It gives me great pleasure to introduce Phil Thomson, something I haven't caught up with for a while. So Phil thanks for joining us. Phil is the President of Global Affairs at GSK. So he's going to provide us with a presentation just to kick off this session, and then we're going to move into Q&A.

So if you have a question, you can send them through the chat box to me and also (inaudible) together and -- for Phil to go through. But otherwise, Phil, over to you. Thanks so much for joining us. It's great to see you again. Let's kick off with the presentation, then we'll move to Q&A.

Philip C. Thomson
GlaxoSmithKline plc - President of Global Affairs

Great. Thanks, Mark. It's great to be here virtually with you. And as you say, caught up for a long time, but it's great to do so. So thank you.

So I thought I'd start, as you said, with a few slides, just to orientate everybody on GSK's approach to ESG. And I'm hoping that people can see the slides because I can't.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot